All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news


← First12345...781Next →

hiv & aids news selected from other sources

  • Epidemiology
    STD rates sharply rise in U.S. says CDC – Will misinformation from PrEP critics prevail?
    Project Inform | 1 hour ago

    The Centers for Disease Control and Prevention (CDC) just published a report on the rates of chlamydia, gonorrhea and syphilis in 2015, finding the highest number of case reports on these infections in 20 years and a steep increase over the last reported period in 2014. Is this a cause for concern? Absolutely. But, as will inevitably be the case, there are going to be questions about whether increasing use of pre-exposure prophylaxis (PrEP) is to blame and the answer is pretty conclusively “no” as far as one can tell from the available data and the CDC as much as says so.

  • Circumcision
    HIVR4P 2016: Circumcision offers major contribution to ending HIV epidemic as a public health threat
    Science Speaks | 12 hours ago

    Kenya’s medical circumcision program launched early with ambition, charting circumcisions performed for 1.3 million men by the end of 2015, leaving evaluators asking what is and what will be the impact of this HIV prevention intervention on the epidemic?

  • PrEP
    First year Amsterdam PrEP project complete
    GGD Amsterdam | 24 October 2016

    Last year the Public Health Service of Amsterdam (GGD) started the Amsterdam PrEP project, a research project focused on the applicability of PrEP for HIV prevention among men who have sex with men (MSM) and transgender individuals. We now have a picture of the first 200 participants and of national developments over the past year. Almost three-quarters of participants preferred daily PrEP to event-based use (before and after sex). PrEP protected almost all participants from HIV. Two participants contracted an HIV infection in the past year. (To read the press release in English, click the link on the right-hand side of the page).

  • PrEP
    Report recommends PrEP for use in Scotland
    HIV Scotland | 24 October 2016

    Last week, a report recommending PrEP for use in Scotland was endorsed by the Executive Leads Network, who govern Scotland's Sexual Health and Blood Borne Virus Framework. The report was written by the Scottish HIV PrEP Short Life Working Group (SLWG), administered by HIV Scotland and chaired by Dr Rak Nandwani.

  • New and experimental HIV treatments
    New nanomedicine approach aims to improve HIV drug therapies
    Science Daily | 24 October 2016

    New research led by the University of Liverpool aims to improve the administration and availability of drug therapies to HIV patients through the use of nanotechnology.

  • Hepatitis C treatment
    A promising Hep C program seems to be working — and it could be a model for other countries
    Business Insider | 24 October 2016

    Georgia, a country nestled against the Black Sea between Turkey and Russia with a population of 3.7 million, has since taken on a public health effort to help reduce its prevalence of hepatitis C (HCV for short) by 90% by 2020.

  • The search for a cure
    Gene therapy goes global: Portable device could make future cancer, HIV cures affordable
    Fred Hutchinson Cancer Research Center | 21 October 2016

    A tabletop device that enables medical staff to genetically manipulate a patient’s blood to deliver potential new therapies for cancer, HIV and other diseases would eliminate the need for multimillion-dollar “clean rooms,” making gene therapy more possible for even the poorest of countries.

  • PrEP
    Norway to provide free HIV-preventing PrEP drugs to at-risk gay men
    Pink News | 21 October 2016

    Norway has this week become the second country in Europe to make PrEP available, announcing that PrEP drugs will be available free of charge to at-risk groups via its National Health Scheme. According to HIV Norway, Minister for Health and Social Care Bent Høie announced the move, making Norway the first country in Europe to make the drug completely free for users (French users have to pay a small and largely reimbursible upfront fee.)

  • Experiences of stigma
    NHS Under Pressure To Explain “Homophobic” Response To HIV Drug Ruling
    BuzzFeed | 21 October 2016

    NHS England is facing calls from leading HIV charities and a Conservative MP to explain why it heavily edited a press statement on a court ruling about an HIV prevention drug to include lines that have been described as “homophobic” and “irresponsible”.

  • The search for a cure
    HIV active in tissues of patients who were treated, study shows
    Eurekalert Inf Dis | 20 October 2016

    UCSF researchers have found in autopsy tissue samples of patients treated with antiretrovirals that the virus evolved and migrated among tissues similar to the way it did in patients who had never received antiretroviral treatment, despite the fact that the treated patients had undetectable levels of virus in their blood.

← First12345...1246Next →

Conference news

Latest news from the HIV Research For Prevention (R4P) conference.

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

Achieving the 90-90-90 target

With advances in HIV testing, treatment and care, some countries are making great progress towards the UNAIDS 90-90-90 target.

aidsmap news apps

Download the free aidsmap news iPhone and android apps.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap